Drug diversion — the unauthorized transfer of controlled substances from their intended clinical use — is one of the most pervasive, costly, and underreported risks in healthcare. Despite decades of regulatory frameworks, detection technology, and compliance investment, the problem continues to grow.
Links Medical Products (LMP) is committed to delivering innovative, high-quality healthcare solutions that improve patient outcomes and support caregivers across the markets we serve. With a focus on clinical performance, reliability, and safety, our portfolio is designed to meet the evolving needs of post-acute care, pharmacy, hospice, EMS, and veterinary providers. Under the leadership of Patrick Buckley, President & CEO, LMP continues to expand its offerings and reinforce its reputation as a trusted partner in healthcare.
This post is related to:
